Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether there is a change in patient-reported
pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of
normal saline.
Phase:
N/A
Details
Lead Sponsor:
Boston Urogynecology Associates
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA